The mechanism of action consists of binding to CD3 on the surface of T cells and CD19 on leukemia cells, initiating T cell receptor-mediated activation, and killing CD19-positive B-ALL (Figure 1) [89,90]. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.